As we have said for quite some time,
"when the penny drops" ,
a valuation that reflects future revenues across the platforms will start to build. Proof of concept for the first B Cell vaccine is essentially proof of concept for many more to follow.
Davy: "We are also definitely (in my view) "undervalued" and "not well understood by the market."
Have you given much consideration Dave to a break down of "Sum of the Parts" Total Valuation ?
At today's price based off the Turnstone/Takeda pre clinical deal CF33 might be considered valued at half fair value. Leaving the further advanced HerVax at late stage Ph 2 , and Pd1 Vaxx with preliminary Ph1 safety showing ,valued at zero. Absurd really. All are game changers.
Personally i don't see any upside or understanding from the Mimitope platform factored in at this level.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-1185
-
-
- There are more pages in this discussion • 13,637 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $411.5M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.5¢ | $390.3K | 7.001M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 124999 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1243276 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 124999 | 0.056 |
16 | 3368018 | 0.055 |
17 | 1759714 | 0.054 |
17 | 2548904 | 0.053 |
18 | 1445326 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 1243276 | 11 |
0.058 | 1322759 | 8 |
0.059 | 578706 | 3 |
0.060 | 1958212 | 14 |
0.061 | 1091000 | 7 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |